BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Acheampong DO, Adokoh CK, Asante DB, Asiamah EA, Barnie PA, Bonsu DOM, Kyei F. Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy. Biomed Pharmacother 2018;97:225-32. [PMID: 29091870 DOI: 10.1016/j.biopha.2017.10.100] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
Number Citing Articles
1 Kang S, Wang L, Xu L, Wang R, Kang Q, Gao X, Yu L. Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype. Oncogene 2022. [PMID: 36097193 DOI: 10.1038/s41388-022-02455-y] [Reference Citation Analysis]
2 Castaño-bonilla T, Barragán E, Sargas C, Sanz A, Algarra L, Herrera-puente P, García-boyero R, Barrios M, Martinez-cuadron D, Rodriguez-veiga R, Boluda B, Gil C, Serrano-lópez J, Martínez-lópez J, Sayas-lloris MJ, Olave MT, Riaza-grau R, Castillo TB, Larrayoz MJ, Amigo R, Jiménez-velasco A, Sánchez J, Ayala R, Blas C, Lainez D, Serrano-lópez J, Sanz MA, Alonso-domínguez JM, Montesinos P, El-khazragy N. No Evidence that CD33 rs12459419 Polymorphism Predicts Gemtuzumab Ozogamicin Response in Consolidation Treatment of Acute Myeloid Leukemia Patients: Experience of the PETHEMA Group. Disease Markers 2022;2022:1-9. [DOI: 10.1155/2022/3132941] [Reference Citation Analysis]
3 Silva M, Martins D, Mendes F. The Role of Immune Checkpoint Blockade in Acute Myeloid Leukemia. Onco 2022;2:164-180. [DOI: 10.3390/onco2030011] [Reference Citation Analysis]
4 Kang S, Li Y, Qiao J, Meng X, He Z, Gao X, Yu L. Antigen-Specific TCR-T Cells for Acute Myeloid Leukemia: State of the Art and Challenges. Front Oncol 2022;12:787108. [PMID: 35356211 DOI: 10.3389/fonc.2022.787108] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Bolandi SM, Pakjoo M, Beigi P, Kiani M, Allahgholipour A, Goudarzi N, Khorashad JS, Eiring AM. A Role for the Bone Marrow Microenvironment in Drug Resistance of Acute Myeloid Leukemia. Cells 2021;10:2833. [PMID: 34831055 DOI: 10.3390/cells10112833] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Kaleka G, Schiller G. Immunotherapy for Acute Myeloid Leukemia: Allogeneic hematopoietic cell transplantation is here to stay. Leuk Res 2021;112:106732. [PMID: 34864447 DOI: 10.1016/j.leukres.2021.106732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Jia M, Zhang H, Wang L, Zhao L, Fan S, Xi Y. Identification of mast cells as a candidate significant target of immunotherapy for acute myeloid leukemia. Hematology 2021;26:284-94. [PMID: 33648435 DOI: 10.1080/16078454.2021.1889158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Haykal T, Younes M, El Khoury M, Ammoury C, Tannous S, Hodroj MH, Sarkis R, Gasilova N, Menin L, Rizk S. The pro-apoptotic properties of a phytonutrient rich infusion of A. cherimola leaf extract on AML cells. Biomed Pharmacother 2021;140:111592. [PMID: 34088572 DOI: 10.1016/j.biopha.2021.111592] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Sun Y, Wan J, Song Q, Luo C, Li X, Luo Y, Huang X, Ding R, Li H, Hou Y, Huang Y, Xie M, Huang Z, Zhang Y, Ma Y, Wu G, Xu S, Chen J. Prognostic Significance of CD56 Antigen Expression in Patients with De Novo Non-M3 Acute Myeloid Leukemia. Biomed Res Int 2021;2021:1929357. [PMID: 33928145 DOI: 10.1155/2021/1929357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xiao Y, Deng T, Ming X, Xu J. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling. Biosci Rep 2020;40:BSR20194334. [PMID: 32232394 DOI: 10.1042/BSR20194334] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
11 Swatler J, Turos-Korgul L, Kozlowska E, Piwocka K. Immunosuppressive Cell Subsets and Factors in Myeloid Leukemias. Cancers (Basel) 2021;13:1203. [PMID: 33801964 DOI: 10.3390/cancers13061203] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
12 Elcheva IA, Spiegelman VS. The Role of cis- and trans-Acting RNA Regulatory Elements in Leukemia. Cancers (Basel) 2020;12:E3854. [PMID: 33419342 DOI: 10.3390/cancers12123854] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
13 López DJ, Rodríguez JA, Bañuelos S. Nucleophosmin, a multifunctional nucleolar organizer with a role in DNA repair. Biochim Biophys Acta Proteins Proteom 2020;1868:140532. [PMID: 32853771 DOI: 10.1016/j.bbapap.2020.140532] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
14 Valhondo I, Hassouneh F, Lopez-Sejas N, Pera A, Sanchez-Correa B, Guerrero B, Bergua JM, Arcos MJ, Bañas H, Casas-Avilés I, Sanchez-Garcia J, Serrano J, Martin C, Duran E, Alonso C, Solana R, Tarazona R. Characterization of the DNAM-1, TIGIT and TACTILE Axis on Circulating NK, NKT-Like and T Cell Subsets in Patients with Acute Myeloid Leukemia. Cancers (Basel) 2020;12:E2171. [PMID: 32764229 DOI: 10.3390/cancers12082171] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
15 Hu X, Chen F. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia. Hematology 2019;24:651-60. [PMID: 31533545 DOI: 10.1080/16078454.2019.1666219] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Ocadlikova D, Lecciso M, Isidori A, Loscocco F, Visani G, Amadori S, Cavo M, Curti A. Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia. Front Oncol 2019;9:1004. [PMID: 31649875 DOI: 10.3389/fonc.2019.01004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
17 Zhong Q, Li BH, Zhu QQ, Zhang ZM, Zou ZH, Jin YH. The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia. Front Pharmacol 2019;10:1100. [PMID: 31611792 DOI: 10.3389/fphar.2019.01100] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
18 Xue L, Hu Y, Wang J, Liu X, Wang X. T cells targeting multiple tumor-associated antigens as a postremission treatment to prevent or delay relapse in acute myeloid leukemia. Cancer Manag Res 2019;11:6467-76. [PMID: 31406473 DOI: 10.2147/CMAR.S205296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Acheampong DO. Bispecific Antibody (bsAb) Construct Formats and their Application in Cancer Therapy. PPL 2019;26:479-93. [DOI: 10.2174/0929866526666190311163820] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
20 Loew A, Köhnke T, Rehbeil E, Pietzner A, Weylandt KH. A Role for Lipid Mediators in Acute Myeloid Leukemia. Int J Mol Sci 2019;20:E2425. [PMID: 31100828 DOI: 10.3390/ijms20102425] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
21 Hwang D, Kim M, Park H, Jeong MI, Jung W, Kim B. Natural Products and Acute Myeloid Leukemia: A Review Highlighting Mechanisms of Action. Nutrients 2019;11:E1010. [PMID: 31058874 DOI: 10.3390/nu11051010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
22 Pei X, Huang X. New approaches in allogenic transplantation in AML. Semin Hematol 2019;56:147-54. [PMID: 30926091 DOI: 10.1053/j.seminhematol.2018.08.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
23 Zhang K, Wang L, Si S, Sun Y, Pei W, Ming Y, Sun L. Crocin improves the proliferation and cytotoxic function of T cells in children with acute lymphoblastic leukemia. Biomed Pharmacother 2018;99:96-100. [PMID: 29329036 DOI: 10.1016/j.biopha.2018.01.042] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]